Farshid Siadat, MD, FRCPC

@latinsnakz The lipid rich shows lipoblast-like morphology.

Lipid-rich urothelial carcinoma. It is a rare and high grade variant with large lipoblast-like cells with cytoplasmic vacuoles indenting the nuclei. #gupath #pathology #Bladdercancer

USCAP was saddened to learn of the passing of Dr. Christopher D.M. Fletcher. Dr. Fletcher was an exceptional and innovative pathologist who dedicated many years in service to USCAP, including serving as President. He will be missed both personally and professionally.

Exceptional speakers panel at the KTF 2024 in Mikulov, Czech Republic. Such a wonderful opportunity to learn & (re)connect with friends and mentors. Bye bye Mikulov! It was a wonderful experience 😊 #PathTwitter

6th Kidney Tumor Friends happening in memory of Ondra Hes in beautiful wine growing area Mikulov, CZ. which was sacred to him. Pre meeting fun and bonding times @Kiril_T_Can @RAlaghehbandan @GU_Path_Society @Williamson_SR @maria_picken @pathmingzhou @FSiadat

Mixed small cell neuroendocrine carcinoma (SCNEC) and urothelial carcinoma. The presence of a NEC component should alert the clinician to consider the potential role of neoadjuvant/adjuvant chemotherapy. #gupath #bladdercancer

Attention GUPS members! Your FINAL chance to have your vote counted! GUPS 2023 election will close on February 14, 2023. #gupath

Exciting, unexpected opportunity! We have an opening for 2023-2024 #GUPath funded fellowship at one of the largest centralized GU practices in #Canada and North America. Join us in #Calgary and gain valuable experience in a dynamic & challenging field. #Pathology #Fellowship

Someone should write a thriller about a pathologist who confesses to murder IN ALL CAPS in the Comment of every pathology report but gets away with it because no one ever reads anything below the Final Diagnosis.

Just published in European Urology: "European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View" Free link: authors.elsevier.com/c/1g81F14kplrL… #kidney #gupath

GUPS members voiced their opinion on reclassifying Grade Group 1 prostate cancer as non-cancer. 81.7% opposed, 13.8% supported and 4.6% uncertain about, removing the cancer label from GG1 cancer. Read more: authors.elsevier.com/a/1g7zZ3r93nVD…. Thank you all for participating in this survey.

Confused with all new kidney tumors? ➡️ Free access to our review paper for 50 days: "Kidney tumors: new and emerging kidney tumor entities" authors.elsevier.com/a/1fvZ5_gfqVL3… Just published in Surgical #Pathology Clinics - book edited by @pathmingzhou #pathtwitter @FSiadat #GUPS

@SaleebRola @CAPACP Congrats!

Extremely proud of @CAPACP junior scientist award. Such an honour!

Did I mention the view is breathtaking around here? #gupath Banff #pathology course 2022.

@SaleebRola on recent updates on PRCC in #gupath Banff #pathology course.

#gupath Banff #pathology course, September 2022.

@DrCristinaMagi explains the meaning of “cribriform” - at the Banff Path Course 2022 - Uropath Update #prostate #ProstateCancer #gupath #pathology #path

@DrCristinaMagi lectures on the #ProstateCancer state of the art in 2022 at the Banff Pathology Course in beautiful #Banff #Canada

@Kiril_T_Can on #ProstateCancer mimickers, 2022 #GUpath Banff #Pathology Course.

#gupath Banff #Pathology Course 2022, day 2

Kicking off the 2nd day of #gupath Banff #pathology Course by @DrCristinaMagi talk on #ProstateCancer updates.